Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-22-000502
Filing Date
2022-11-04
Accepted
2022-11-04 17:15:45
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2022 bivi-20220930_10q.htm   iXBRL 10-Q 703205
2 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT bivi-20220930_10qex10z2.htm EX-10.2 98513
3 EXHIBIT 31.1 bivi-20220930_10qex31z1.htm EX-31.1 12097
4 EXHIBIT 31.2 bivi-20220930_10qex31z2.htm EX-31.2 12261
5 EXHIBIT 32.1 bivi-20220930_10qex32z1.htm EX-32.1 5287
6 EXHIBIT 32.2 bivi-20220930_10qex32z2.htm EX-32.2 5140
  Complete submission text file 0001520138-22-000502.txt   4285793

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bivi-20220930.xsd EX-101.SCH 40608
8 XBRL CALCULATION FILE bivi-20220930_cal.xml EX-101.CAL 41917
9 XBRL DEFINITION FILE bivi-20220930_def.xml EX-101.DEF 134619
10 XBRL LABEL FILE bivi-20220930_lab.xml EX-101.LAB 276064
11 XBRL PRESENTATION FILE bivi-20220930_pre.xml EX-101.PRE 236921
63 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20220930_10q_htm.xml XML 644751
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 221363081
SIC: 2834 Pharmaceutical Preparations